HOPS 2026 Returns to Dubai — Setting a New Benchmark for Oncology Pharmacy in the Middle East
The 2nd Annual Hematology-Oncology Pharmacy Summit (HOPS 2026) is set to take place on 16–17 January 2026 at Conrad Dubai, bringing together oncology pharmacists, clinicians, researchers, and industry leaders from across the Middle East and beyond. The Summit aims to drive clinical excellence, collaborative care, and innovation in cancer pharmacotherapy.
HOPS returns stronger in its second edition — offering a comprehensive, clinically oriented program designed around the most advanced and emerging trends in oncology pharmacy. Attendees will benefit from sessions covering topics such as CAR-T and cellular therapies, gene therapy, bispecific antibodies, precision hematology, transformative pharmacotherapy in malignant and benign hematology, pharmacy-driven supportive care, operational excellence for advanced therapies, and health-technology integration in oncology pharmacy.
“We are entering a new era in cancer care — one defined not only by scientific breakthroughs, but by the leaders who know how to translate innovation into meaningful outcomes for patients,” says Sana Alblooshi, Summit Chairperson. “HOPS 2026 is more than a conference; it is a regional movement to elevate oncology-pharmacy practice, equip our professionals with future-ready capabilities, and build a sustainable ecosystem of excellence that will shape the next decade of cancer care in the Gulf.”
At the heart of HOPS 2026 is a distinguished Scientific Committee comprised of regional and international leaders in hematology, oncology pharmacy, and clinical research — including members from the Gulf region and beyond. Their collective expertise ensures a program grounded in scientific rigor and clinical relevance.
The Summit is expected to draw 400+ attendees, feature 50+ expert speakers, and present 40+ up-to-date scientific presentations, enabling a rich combination of knowledge exchange, professional development, and networking.
HOPS 2026 is especially relevant for: medical oncologists; oncology and clinical pharmacists; pharmacy technicians; residents, students, and academics; oncology nurses; regulatory and compliance professionals; as well as representatives from the pharmaceutical industry and patients’ advocacy organizations. The Summit’s multidisciplinary approach offers a unique platform for collaboration, research dissemination, and shared progress in cancer care.
Registration for HOPS 2026 is now open. Early-bird rates are available until 20 December 2025. For more information, including program details, registration categories, and abstract submission guidelines, please visit the official website: hops-uae.com.
About HOPS
HOPS is a dedicated oncology pharmacy summit committed to advancing hematology and oncology pharmacy practice in the Middle East. Through scientific sessions, workshops, research presentations, and expert-led discussions, HOPS aims to elevate standards of care, foster regional collaboration, and support the professional growth of oncology pharmacy practitioners.
Website: https://hops-uae.com/
Media Contact:
Johnilyn Opus
Event Manager
info@hops-uae.com
(+971) 52 702 7924
